The latest Ebola Treatment: Human trials of the vaccine to start next week

Aug 16, 2017 | | Say something

The latest Ebola Treatment: Human trials of the vaccine to start next week ;

Ebola treatment
The US government States announced Thursday that it will begin human trials of Ebola vaccine early next week. The National Institutes of Health (NIH) said in a statement that the phase of a clinical trial will determine whether a vaccine, co-developed by the National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline (GSK), is safe and induces an adequate immune response, Xinhua said.

The tests were conducted at the NIH Clinical Center in Bethesda, Maryland, with 20 healthy adults aged 18 to 50 who received an intramuscular injection of the vaccine, he said. In addition, the NIH and a British consortium, including the Wellcome Trust, will test the vaccine / GSK NIAID among healthy volunteers in Britain and the West African countries of Gambia and Mali, the agency said.

The US government is also discussing a trial of the vaccine in Nigeria, Africa’s most populous country.
‘There is an urgent need for a protective vaccine Ebola, and it is important to establish that the vaccine is safe and spurs the immune system to react in a necessary way to protect against infection, “NIAID director Anthony Fauci said in a press release.

said GSK said in a statement that the British consortium that also involved the British government has pledged some $ 4.6 million for the Phase one is expected to be completed by end of 2014 .

according to the World Health Organization, at least 1,552 suspected and confirmed deaths from Ebola infection have been reported in Guinea, Liberia, Nigeria and Sierra Leone since the outbreak the deadly virus first reported in March 2014.

Other vaccines and treatment of Ebola:

the zmapp

Until now the most effective drug against Ebola virus has proven to be the zmapp – a combination of antibodies – which has helped cure two American doctors. The drug is designed to attack and inactivate the Ebola virus, and is a combination of three different antibodies. The zmapp works the same way our natural immune system makes it only more specifically.

Japan Avigan

Japan has said it is ready to provide an anti-influenza drug developed Japanese to treat the deadly Ebola virus. Cabinet Secretary Yoshihide Suga told a news agency: “Our country is prepared to provide the drug to approved in cooperation with the manufacturer if the WHO calls” The drug is called Avigan and has been developed by Fujifilm Holdings Corp.. subsidiary of Japan chemical Toyama. the generic name of the drug is favipiravir. the company is also in talks with the FDA to expand the use of drugs to treat Ebola.

Canadian Ebola vaccine

a vaccine developed by Canadian company ImmunoVaccine Inc., was found to be protective against Ebola virus in animals. Four monkeys infected with virus Ebola survived after being injected vaccine the company declared the results of the study on Monday that caused their stock markets soar high (read: Ebola vaccine on the way )..

the company based in Scotland Halifax, Nova said the four monkeys were vaccinated first and later a lethal dose of Ebola virus was injected in them. While these four animals survived the viral attack, two monkeys in the control group, who did not receive the vaccine, he died within a week. The company began production of the vaccine against Ebola few months after the US National Institutes of Health (NIH) suggests ImmunoVaccine to develop the vaccine for Ebola application of the technology used by the company in vaccine development against Anthrax. (Read: Canada donates experimental vaccine against Ebola WHO)

The work of production of the vaccine was a part of the tests of NIH potential antigens , agents (substances) that activate the immune system to produce antibodies against the Ebola virus. The antigen present in the vaccine does not use a single virus to attack cells unlike other vaccines antigens Ebola early stage. (Read: Ebola virus – causes, symptoms, diagnosis, treatment, prognosis and prevention )

What is Ebola?

The disease Ebola (EVD) virus, formerly known as Ebola hemorrhagic fever is a serious disease caused by a virus of the family Filoviridae . Is known to be a condition that is transmitted from animals to humans, this virus spreads through direct contact with body fluids of an infected person or animal.

How can it be prevented?

According to Dr. Ratan, ‘There is no vaccine available from now on, so basic hygiene is important and need to be followed in order to prevent the occurrence of the illness. Simple activities such as washing hands thoroughly, drinking water from a clean source, maintaining general hygiene and cooking meat thoroughly, everyone can serve as precautionary measures. Besides people should avoid crowded places or those who are known to have an outbreak. It is also important that if you notice any early symptoms should see a doctor immediately. “

If people in India worry?

‘is not prevalent in India, but people living in remote areas, where living conditions are poor, are always at risk of infection but largely no need to worry as such “Read more about Ebola virus -.. Causes , symptoms, diagnosis, treatment, prognosis and prevention

photo Source: Getty images

with inputs from IANS

may also want to read:

for more articles on diseases and conditions, visit our section diseases and conditions . Follow us on Facebook and Twitter for all the latest updates! For free daily health tips, subscribe to our newsletter . And for health-related queries, visit our Questions and Answers section .

This article was originally published on thehealthsite, Read the original article here

Posted in: Diseases & Conditions, Ebola vaccine, Ebola virus, Ebola virus cure, In the news, Latest Ebola Treatment

Leave a Reply

Your email address will not be published. Required fields are marked *

==[Click 2x to Close X]==
Most Popular Today!